REMELANOTIDE Typical Properties
Product Name:
PT-141
Synonyms:
Bremelanotide;PT141 Acetate,BreMelanotide Acetate;Ac-Nle-cyclo(-Asp-His-D-Phe-Arg-Trp-Lys);Bremelanotide,α-MSH (PT-141);BREMELANOTIDE;Brmelanotice;Ac-Nle-cyclo(-Asp-His-D-Phe-Arg-Trp-Lys)-OH;Bremelanotide, PT141,PT-141
CAS:
189691-06-3
MF:
C50H68N14O10
MW:
1025.18
Product Categories:
Peptides
Mol File:
189691-06-3.mol
density
1.43
pka
3.37±0.70(Predicted)
Bremelanotide Usage
Absrtact Bremelanotide (formerly PT-141) is a compound under drug development by Palatin Technologies as a treatment for female sexual dysfunction, hemorrhagic shock and reperfusion injury.
It functions by activating the melanocortin receptors MC1R and MC4R, to modulate inflammation and limitingischemia.
It was originally tested for intranasal administration in treating female sexual dysfunctionbut this application was temporarily discontinued in 2008 after concerns were raised over adverse side effects of increased blood pressure. As of March, 2012, Palatin is conducting a human Phase 2B study using a new subcutaneous drug delivery system that appears to have little effect on blood pressure.
Bremelanotide Packaging and Shipping
Packaging:1kg/drum, as customer’s request
Shipping:It can be according to the customer’s request
